|
(PQ1) Progression of the airway field of injury to Kras mutant lung cancer
|
5R01CA205608-03
|
$346,909
|
|
SCHEET, PAUL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQ3) Immune epigenetic biomarkers of bladder cancer outcomes
|
1R01CA216265-01
|
$632,860
|
$632,860
|
CHRISTENSEN, BROCK
|
DARTMOUTH COLLEGE
|
|
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
|
5R01CA208756-03
|
$518,165
|
|
HACOHEN, NIR
|
BROAD INSTITUTE, INC.
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
5R01CA208642-03
|
$352,275
|
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
$91,664
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
5P20CA192994-04
|
$277,311
|
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
1/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA203000-04
|
$969,219
|
|
SIMON, MELISSA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership
|
5P20CA202925-03
|
$278,348
|
|
PATIERNO, STEVEN
|
DUKE UNIVERSITY
|
|
2/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA202995-04
|
$789,845
|
|
CIECIERSKI, CHRISTINA
|
NORTHEASTERN ILLINOIS UNIVERSITY
|
|
2018 Annual Meeting of the American Society for Investigative Pathology
|
1R13CA228237-01
|
$15,000
|
|
MITCHELL, RICHARD
|
AMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY
|
|
2018 Lysosomes and Endocytosis Gordon Research Conference and Gordon Research Seminar
|
1R13CA228143-01
|
$3,000
|
|
WEISMAN, LOIS
|
GORDON RESEARCH CONFERENCES
|
|
3/3: The Chicago Collaborative to Promote and Advance Cancer Health Equity
|
5U54CA202997-04
|
$1,566,061
|
|
WINN, ROBERT
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
402 -- A PHASE I TRIAL OF THE SAFETY IMMUNOGENICITY OF RG1-VLP... (PROTOCOL UWI2016-08-02). CONTRACTOR: UNIVERSITY OF WISCONSIN. CONTRACT NO: HHSN261201200033I, TASK ORDER: HHSN261000012. FROM 9/1
|
261201200033I
|
$1,485,915
|
$490,352
|
UNKNOWN, UNKNOWN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
A 3D Model of the Perivascular Niche to Investigate Glioblastoma Invasion
|
1F31CA228317-01
|
$39,703
|
|
WOLF, KAYLA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A combined single cell gene expression and enzyme activity assay to study chemotherapy resistance in pancreatic ductal adenocarcinoma
|
1F31CA228223-01
|
$35,681
|
|
PETERSEN, BRAE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
ZIA BC 011232
|
$339,315
|
$305,384
|
Barchi, Joseph
|
CCR (NCI)
|
|
A high efficiency imager for real-time lung cancer monitoring during radiotherapy
|
5R01CA188446-05
|
$765,486
|
|
BERBECO, ROSS
|
DANA-FARBER CANCER INST
|
|
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
|
5U01CA199252-04
|
$1,041,188
|
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A Phase I Combination Study of Durvalumab and Vicinium in BCG refractory NMIBC
|
ZIA BC 011786
|
$32,548
|
$32,548
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A pooled analysis of dietary long-chain omega-3 fatty acid intake and endometrial cancer risk
|
5R03CA212808-02
|
$78,000
|
|
BRASKY, THEODORE
|
OHIO STATE UNIVERSITY
|
|
A prospective examination of change in executive function and physical activity in older breast cancer survivors.
|
1F31CA220964-01A1
|
$42,314
|
|
TOMETICH, DANIELLE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
A Prospective Investigation of the Oral Microbiome and Pancreatic Cancer
|
5U01CA187508-04
|
$430,565
|
|
PALMER, JULIE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Randomized, Prospective, Phase II Study to Determine the Efficacy of Bacillu
|
ZIA BC 011528
|
$97,645
|
$97,645
|
Agarwal, Piyush
|
CCR (NCI)
|
|
A rapid spontaneous murine model of CN-AML
|
5R01CA196658-03
|
$567,086
|
|
GRIMES, H
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$703,174
|
$35,159
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abbreviated MRI Breast Screening protocol
|
5F31CA217160-02
|
$32,943
|
|
JIMENEZ, JORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Aberrant signaling in acute myeloid leukemia
|
5R01CA204396-03
|
$459,674
|
|
KENTSIS, ALEX
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Accelerating Transdisciplinary Epidemiology of Colorectal Cancer
|
5R35CA197735-04
|
$740,848
|
|
OGINO, SHUJI
|
DANA-FARBER CANCER INST
|
|
Active surveillance and patient reported outcomes in a diverse population of prostate cancer patients
|
5R01CA211141-02
|
$624,859
|
|
GOMEZ, SCARLETT
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu
|
5U54CA190152-05
|
$745,654
|
|
GOPAL, SATISH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology
|
5R33CA206949-03
|
$460,385
|
|
SPICER, TIMOTHY
|
SCRIPPS FLORIDA
|
|
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
|
5U24CA180921-05
|
$705,863
|
$141,173
|
BECICH, MICHAEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Advanced Practice Provider Oncology Web Educational Resource (AP POWER)
|
5R25CA148050-07
|
$158,529
|
|
ROSENZWEIG, MARGARET
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Advancing biological and clinical applications of genomic Minimal Residual Disease detection in AML
|
1R01CA217954-01A1
|
$429,758
|
|
MALEK, SAMI
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Aerobic Training During or After Adjuvant Therapy: A Randomized Trial
|
5R01CA164751-06
|
$515,269
|
|
JONES, LEE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Aging mammary stem cells and breast cancer prevention
|
5R01CA192564-04
|
$395,434
|
|
SUN, LUZHE
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
$41,770
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
$222,902
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance NCORP Research Base
|
5UG1CA189823-05
|
$7,362,635
|
|
BUCKNER, JAN
|
MAYO CLINIC ROCHESTER
|
|
Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment
|
5R01CA208343-02
|
$425,312
|
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
An Integrative Approach to Identify Causal Epigenetic Markers for Breast Cancer
|
5R01CA194030-04
|
$326,701
|
|
HE, CHUNYAN
|
UNIVERSITY OF KENTUCKY
|
|
Analyzing Complex Cancer Studies With Skewed Responses
|
5R03CA205018-02
|
$83,299
|
$83,299
|
LIPSITZ, STUART
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Anastasis, a new mechanism driving cell survival and evolution
|
5DP1CA195760-05
|
$767,500
|
|
MONTELL, DENISE
|
UNIVERSITY OF CALIFORNIA SANTA BARBARA
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,094,457
|
$21,889
|
Barr, Frederic
|
CCR (NCI)
|
|
Applying Chemical Biology to Target Deubiquitinating Enzymes in Lung Cancer
|
5R21CA218787-02
|
$187,050
|
|
HAURA, ERIC
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
ARF1 signaling in prostate cancer
|
5R56CA204315-02
|
$243,960
|
|
WU, GUANGYU
|
AUGUSTA UNIVERSITY
|
|
Assisted Network-based Analysis of Cancer Gene Expression Studies
|
5R03CA216017-02
|
$83,750
|
|
MA, SHUANGGE
|
YALE UNIVERSITY
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,161,432
|
$46,457
|
N/A
|
DCEG (NCI)
|
|
Atypical Chemokine Receptor 4 (ACKR4) in Anti-tumor Immunity in colorectal cancer
|
5R03CA219129-02
|
$73,490
|
|
SUBRAMANIAN, SUBBAYA
|
UNIVERSITY OF MINNESOTA
|
|
Automated Image Guidance for Diagnosing Skin Cancer With Confocal Microscopy
|
5R01CA199673-04
|
$619,539
|
|
RAJADHYAKSHA, MILIND
|
SLOAN-KETTERING INST CAN RESEARCH
|
Total relevant funding to Bladder for this search: $36,824,186
|